Case Study: Surgical Site Infection

Case Study Overview

Patient history

A 63-year-old female with a history of hernia, was admitted to hospital with a hard-to-heal wound on her abdomen in the umbilical area.

The wound had developed within a week of surgery, and on presentation had been present and non-healing for one month.

Initial assessment

Surgical Site Infection before treatment with MaxioCel
Fig 1: Wound at initial presentation

At the time of admission, the wound area was 60×50mm with a depth of 40mm.

The wound had high exudate levels, with 80% sloughy and 20% necrotic tissue (Fig 1).

The patient had a pain score of 7 out of 10 on visual analogue scale (VAS), where ‘0’ represented no pain and ‘10’ represented the worst pain imaginable.

Debridement of the wound area was performed to manage exudate levels and infection, and to maintain the moisture level of the wound.

Previous Treatment

As part of the previous treatment regimen, a povidone-iodine solution-soaked gauze had been applied to prevent infection on the wound area, and surgical debridement had been performed, due to persistent infections, along with other supportive treatments to manage the patient’s condition.

The povidone-iodine dressings did not resolve the problem in this patient’s case.

Method

As MaxioCel is a highly absorbent wound dressing with haemostatic, antimicrobial properties, as well as evidence of improving patient comfort, clinicians decided to commence treatment with MaxioCel.

Throughout the course of treatment, MaxioCel was used and changed on alternate days, with a total of 30 dressings used (10×10cm).

 

Results

During 60 days of treatment with MaxioCel, healing of the wound progressed significantly, despite the complex conditions of the wound (high level of exudate, infection, depth and pain).

The results achieved included reduction in pain and exudate levels, along with reduction of infection, and prevention of the onset of any further infection.

The ease of application and removal of the dressing, and comfort level of the patient with use of this dressing, were found to be excellent. The patient reported that the dressing was comfortable to wear.

The wound closed completely after 60 days of treatment.

The results with the use of MaxioCel showed a faster rate of wound healing as compared to previously used povidone-iodine dressings.

Progress photos of surgical site infection during treatment with MaxioCel
Fig 2: Wound healing progression during the use of MaxioCel. The wound area can be seen to be gradually reducing with these dressings, which were changed on alternate days for 60 days. The images clearly show the ability of this dressing to combat surgical site infections. The dressing was able to absorb exudates and helped in hastening the normal wound healing process: 1 day (a); 8 days (b); 16 days (c); 24 days (d); 32 days (e); 40 days (f); 48 days (g); 54 days (h); 60 days (i)

Conclusion

This case represents the advantages of MaxioCel in surgical wounds and suggests that its use can be helpful in preventing complications and promoting healing in post-surgical wounds.

MaxioCel was commenced one month after the surgery. At this time the wound was already infected and inflamed. The wound closed within 60 days.

To read the full case study report, published in the Journal of Wound Care, click here

To request a sample and to learn more about how MaxioCel could help your patients get in touch with us here.

 

“MaxioCel was commenced one month after the surgery. At this time the wound was already infected and inflamed. The wound closed within 60 days.”


The results achieved included reduction in pain and exudate levels, along with reduction of infection, and prevention of the onset of any further infection.

References

Gupta et al, ‘Use of chitosan wound dressing for the treatment of surgical site infection: a case report,’ Journal of Wound Care, March 2023

Request a sample

Evaluate the benefits of MaxioCel for your patients